ReviewAntibiotics (Basel, Switzerland)2020
The Revaluation of Plant-Derived Terpenes to Fight Antibiotic-Resistant Infections.
Review in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 59 citations in OpenAlex.
- Exploration of the aromatic abietane diterpenoid scaffold in the development of ArnT-mediated colistin resistance inhibitors.RSC advances · 2026Article
- Article
- Review
- Unlocking the Potential of Brazilian Plant Terpenes to Combat Antimicrobial Resistance.ACS bio & med chem Au · 2025Review
- Innovative Therapies: A Major Breakthrough in Combating Multi-Drugresistant Bacterial Infections Using Mixture Design and Multi-Objective Optimization with NSGA-II Algorithm.Current topics in medicinal chemistry · 2025Article
- Novel benzothiazole derivatives target the Gac/Rsm two-component system as antibacterial synergists againstActa pharmaceutica Sinica. B · 2024Article
- Antimicrobial Resistance in Aquaculture: Risk Mitigation within the One Health Context.Foods (Basel, Switzerland) · 2024Review
- Mechanism of antibacterial phytoconstituents: an updated review.Archives of microbiology · 2024Review
- Enantioselective and collective total synthesis of pentacyclic 19-Chemical science · 2023Article
- Review
- Antibacterial Activity of the Essential Oil ofPlants (Basel, Switzerland) · 2023Article
- Synthetic and Semisynthetic Compounds as Antibacterials Targeting Virulence Traits in Resistant Strains: A Narrative Updated Review.Antibiotics (Basel, Switzerland) · 2023Review
- Yeast Particles for Encapsulation of Terpenes and Essential Oils.Molecules (Basel, Switzerland) · 2023Review
- Yeast Particles Hyper-Loaded with Terpenes for Biocide Applications.Molecules (Basel, Switzerland) · 2022Article
- Phytochemical Profile of Antibacterial Agents from Red Betel Leaf (Molecules (Basel, Switzerland) · 2022Review
- Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Development of New Antimicrobial Oleanonic Acid Polyamine Conjugates.Antibiotics (Basel, Switzerland) · 2022Article
- Plumbagin resurrect colistin susceptible against colistin-resistantFrontiers in microbiology · 2022Article
- Rhein inhibitsFrontiers in public health · 2022Article
- Labdane Diterpenoids fromMolecules (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
The discovery of antibiotics has revolutionized the medicine and treatment of microbial infections. However, the current scenario has highlighted the difficulties in marketing new antibiotics and an exponential increase in the appearance of resistant strains. On the other hand, research in the field of drug-discovery has revaluated the potential of natural products as a unique source for new biologically active molecules and scaffolds for the medicinal chemistry. In this review, we first contextualized the worldwide problem of antibiotic resistance and the importance that natural products of plant origin acquire as a source of new lead compounds. We then focused on terpenes and their potential development as antimicrobials, highlighting those studies that showed an activity against conventional antibiotic-resistant strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.